Conference abstract · 29 May 2023
Conference abstractPublished 17 Sep 2018
Diabetic cardiomyopathy
Sisli Memorial Hospital Istanbul, Turkey
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Diabetic cardiomyopathy is a clinical condition which is diagnosed when ventricular dysfunction occurs in the absence of atherosclerosis and hypertension in diabetic patients. Myocardial dysfunction is diastolic at the beginning, but in later stages contraction dysfunction develops and systolic dysfunction also occurs. Heart failure guidelines published in 2013 state that Diabetes Mellitus (DM) is now well recognized risk factor for development of heart failure independent of age, hypertension, obesity, hypercholesterolemia and coronary artery disease. Currently diagnosing diabetic cardiomyopathy is based on noninvasive imaging techniques. In DM, both gluco and lipo-toxicities are responsible for increasing oxidative stress and chronic inflammation which leads to micro-vasculopathy. Reduced coronary microcirculation leads to chronic myocardial ischemia which causes pathological cardiac re-modeling which in turn leads to subsequent Diastolic Dysfunction (DD). Both reduced Coronary Flow Reserve (CFR) and DD are associated with Left Ventricular (LV) concentric remodeling, hypertrophy, abnormalities of angiotensin-renin system and with endothelial dysfunction. Therefore, it is proposed that coronary microvascular damage plays a mechanistic role for DD. Myocardial fibrosis and collagen deposition are the primary structural changes observed in diabetic cardiomyopathy. Therefore, impaired LV function observed in diabetic patients can be the result of fibrosis and altered collagen structure. Left Ventricular Hypertrophy (LVH) has been associated with DM independent of other factors (such as obesity, hypertension, or age). Prevalence of DD in diabetic patients is high, ranging from 21% to 75%. Diastolic dysfunction is considered as the first marker of diabetic cardiomyopathy. Both LVH and DD can be demonstrable by echocardiographic techniques. Subclinical LV dysfunction in asymptomatic diabetic patients may be assessed by speckle tracking echocardiography. Subclinical LV longitudinal dysfunction is frequently observed in asymptomatic diabetes patients with normal ejection fraction. Diabetes is an independent risk factor for heart failure. Micro-vasculopathy, myocardial fibrosis and myocardial steatosis all play a role in the pathogenesis of diabetic cardiomyopthy. Echocardiography can demonstrate the functional changes in diabetes such as LVH, DD and myocardial longitudinal function.
Subjects
CardiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Short communication · 30 May 2022
Current status on the healing techniques for coronary heart failure and diabetic cardiomyopathy.
Perspective · 28 Apr 2022
Diabetes Mellitus as a Cause or Consequence of Diabetic Cardiomyopathy
Mini review · 18 Feb 2022
Progression of therapeutic strategies on diabetic cardiomyopathy.
Commentary · 28 Jan 2022
Diabetic related cardiomyopathy: Commentary
More from this journal
The newest in Clinical and Experimental Cardiology.
Short communication · 4 Aug 2026
An effective determination method for aortic valve replacement through minimally invasive lower median sternotomy
Conference abstract · 15 Jun 2026
Speckle Tracking Echocardiography for Early Identification of Chemotherapy-Induced Cardiotoxicity
Conference abstract · 15 Jun 2026
Coronary CT Angiography as a First-Line Diagnostic Tool for Stable Chest Pain: Clinical Outcomes from a Multicenter Study
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalClinical and Experimental Cardiology
- SubjectCardiology
- BylineArticles whose byline prints “Sibel Catirli Enar”

